ME Therapeutics Holdings Inc. (CSE:METX)

ME Therapeutics Holdings Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	1.35	1.5	0.65	0.08	0.07
Short-Term Investments	0.06	-	-	-	-
Cash & Short-Term Investments	1.4	1.5	0.65	0.08	0.07
Cash Growth	-6.27%	131.28%	736.35%	5.91%	47.00%
Other Receivables	0.07	0.02	0.01	0.02	0
Receivables	0.07	0.02	0.01	0.02	0
Prepaid Expenses	0.03	0.03	0.02	0	-
Total Current Assets	1.5	1.54	0.67	0.1	0.08
Property, Plant & Equipment	0.25	0	0	0	0
Other Intangible Assets	0	0	0	0	0
Other Long-Term Assets	0.01	-	-	-	-
Total Assets	1.76	1.54	0.67	0.1	0.08
Accounts Payable	0.16	0.05	0.11	0.02	0.03
Accrued Expenses	0.01	0.02	-	-	-
Short-Term Debt	-	-	-	0.13	-
Current Portion of Long-Term Debt	-	-	0.04	-	-
Current Portion of Leases	0.06	-	-	-	-
Other Current Liabilities	0.01	-	0	0.02	0.01
Total Current Liabilities	0.25	0.06	0.15	0.17	0.03
Long-Term Debt	-	-	-	0.06	0.06
Long-Term Leases	0.01	-	-	-	-
Total Liabilities	0.26	0.06	0.15	0.23	0.09
Common Stock	8.59	6.11	4.52	0.51	0.51
Retained Earnings	-9.73	-8.54	-7.24	-0.72	-0.57
Comprehensive Income & Other	2.64	3.9	3.24	0.08	0.04
Shareholders' Equity	1.5	1.48	0.52	-0.13	-0.02
Total Liabilities & Equity	1.76	1.54	0.67	0.1	0.08
Total Debt	0.07	-	0.04	0.19	0.06
Net Cash (Debt)	1.33	1.5	0.61	-0.12	0.01
Net Cash Growth	-11.06%	146.52%	-	-	34.62%
Net Cash Per Share	0.05	0.06	0.04	-0.01	0.00
Filing Date Shares Outstanding	30.05	25.19	23.56	6.08	6.08
Total Common Shares Outstanding	29.59	25.19	23.56	6.08	6.08
Working Capital	1.26	1.48	0.52	-0.07	0.04
Book Value Per Share	0.05	0.06	0.02	-0.02	-0.00
Tangible Book Value	1.5	1.48	0.52	-0.13	-0.02
Tangible Book Value Per Share	0.05	0.06	0.02	-0.02	-0.00
Machinery	0.19	0	0	0	0
Leasehold Improvements	0.03	-	-	-	-

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.